Detalles de la búsqueda
1.
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Haematol
; 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38885672
2.
Monoclonal gammopathy of undetermined significance (MGUS) characterized by refractory lower gastrointestinal postoperative bleeding with coagulopathy.
Intractable Rare Dis Res
; 11(4): 206-210, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36457584
3.
Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A.
Clin Appl Thromb Hemost
; 27: 1076029621989811, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587652
4.
Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 Trial.
Ther Clin Risk Manag
; 16: 567-578, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32606716
5.
Chinese guidelines for treatment of adult primary immune thrombocytopenia.
Int J Hematol
; 107(6): 615-623, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29619624
6.
[Expression of Hydrodynamic Injection-mediated PD-L1 in Myeloablative Conditioning Mouse Model].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 23(5): 1432-7, 2015 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-26524052
7.
[Total knee arthroplasty for the treatment of hemophilic arthropathy of the knee].
Zhongguo Gu Shang
; 24(12): 1001-4, 2011 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-22276508
Resultados
1 -
7
de 7
1
Próxima >
>>